Copenhagen, Denmark

Ulrik Sørensen

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Acesion Pharma Aps. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrik Sørensen. Retrieved from https://idiyas.com/inventor/ulrik-sørensen-s17g25f7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrik Sørensen: Innovator in Cardiac Treatment

Introduction

Ulrik Sørensen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of potassium channel inhibitors. His work focuses on innovative solutions for treating cardiac diseases, disorders, and conditions.

Latest Patents

Ulrik Sørensen holds a patent for a compound of the general formula (I), which includes a pharmaceutical composition that may contain a pharmaceutically acceptable additive. This invention is aimed at the treatment of cardiac diseases in mammals, involving the administration of a therapeutically effective amount of at least one compound of formula (I) or its pharmaceutically acceptable salt.

Career Highlights

Ulrik Sørensen is associated with Acesion Pharma Aps, where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments that can improve the quality of life for patients suffering from cardiac conditions.

Collaborations

Ulrik has collaborated with notable professionals in his field, including Antonio Mete. These collaborations enhance the innovative potential of his research and contribute to the advancement of cardiac treatment solutions.

Conclusion

Ulrik Sørensen's contributions to the field of cardiac treatment through his innovative patents and collaborations highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…